An international study of the quality of life of adult patients treated with home parenteral nutrition.

Department of Nutrition and Dietetics, Kings Cross Hospital, Dundee, UK. Electronic address: janetbaxter@nhs.net. Department of Public Health, University of Aberdeen, UK. Faculty of Medicine, Milan, Italy. Oley Foundation for Home Parenteral and Enteral Nutrition, Albany, NY, USA. Centre for Gastroenterology and Nutrition Support, Hôpital Beaujon, Paris, France. Radboud University Nijmegen Medical Centre, Amsterdam, The Netherlands. Academic Medical Centre, Amsterdam, The Netherlands. Hospital General Universitario Gregorio, Maranon, Madrid, Spain. Medico-Surgical Department of Gastroenterology, Hôpital Erasme, Brussels, Belgium. General and Oncology Surgery Unit, Intestinal Failure Center, Stanley Dudrick's Memorial Hospital, Skawina, Poland. Department of Surgery, CHU de Québec, Université Laval, Canada. Department of Gastroenterology, Rigshospitalet, Denmark. Nutrition Services, Auckland City Hospital, New Zealand. Norwich Medical School, University of East Anglia, Norwich, UK. Flinders Medical Centre, Bedford Park, Australia. Hospital Universitario Central de Asturias, Oviedo, Spain. Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; European Palliative Care Research Centre (PRC), Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway. Clinical Epidemiology Unit, Fondazione IRCCS Instituto Nazionale dei Tumozi, Milano, Italy. Centre for Chronic Intestinal Failure, Department of Digestive System, St. Orsola-Malpighi Hospital, University of Bologna, Italy.

Clinical nutrition (Edinburgh, Scotland). 2019;(4):1788-1796
Full text from:

Abstract

BACKGROUND & AIMS Home parenteral nutrition-quality of life (HPN-QOL©) is a self-assessment tool for the measurement of QOL in patients on HPN. The aims of this study were: to re-assess the basic psychometric properties of the HPN-QOL© in a multinational sample of adult patients; to provide a description of QOL dimensions by short and long HPN treatment duration; to explore clinical factors potentially associated to QOL scores. METHODS Patients (n = 699) from 14 countries completed the HPN-QOL©. The questionnaires were analysed to evaluate data completeness, convergent/discriminant validity and internal-consistency reliability. The association of overall QOL and HPN treatment duration as well as other clinical factors were investigated using multivariable linear regression models. RESULTS The analysis of the multitrait-scaling and internal consistency indicates a good fit with the questionnaire structure for most items. Item discriminant validity correlation was satisfactory and psychometric evaluation of the HPN-QOL© in the different English, French and Italian language patient sub-groups confirmed psychometric equivalence of the three questionnaire versions. The results of the multivariable linear regression showed that QOL scores were significantly associated with HPN duration (better in long-term), underlying disease (better in Crohn's disease and mesenteric ischaemia) and living status (worse in living alone) and, after adjusting for the other factors, with the number of days of HPN infusion per week. CONCLUSIONS The HPN-QOL©, is a valid tool for measurement of QOL in patients on HPN, to be used in the clinical practice as well as in research.

Methodological quality

Publication Type : Multicenter Study ; Observational Study

Metadata

MeSH terms : Quality of Life